, Volume 57, Issue 3, pp 645–646 | Cite as

Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?

  • Sara F. Hansson
  • Stella Korsgren
  • Fredrik Pontén
  • Olle Korsgren


Enterovirus Immunohistochemistry Type 1 diabetes VP-1 





Monoclonal antibody


Viral peptide 1



Human pancreatic islets were obtained from the Nordic Network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden) and the JDRF.


This study was supported by grants from the Swedish Medical Research Council (65X-12219-15-6), the Knut and Alice Wallenberg Research Foundation, EU-FP7-Health 2010 PEVNET 261441 and the Novo Nordisk Foundation; OK’s position is in part supported by the National Institutes of Health (2U01AI065192-06).

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

All authors were responsible for the conception and design of the manuscript, drafting the article and revising it critically for important intellectual content. All authors approved the version to be published.


  1. 1.
    Richardson SJ, Leete P, Dhayal S et al (2013) Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. doi: 10.1007/s00125-013-3094-7 Google Scholar
  2. 2.
    Hansson SF, Korsgren S, Ponten F, Korsgren O (2013) Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol 229:719–728PubMedCrossRefGoogle Scholar
  3. 3.
    Dako (2003) Specification sheet for clone 5-D8/1, code no. M 7064. Available from, accessed 29 November 2013
  4. 4.
    Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373–382PubMedCrossRefGoogle Scholar
  5. 5.
    Flodstrom-Tullberg M, Hultcrantz M, Stotland A et al (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174:1171–1177PubMedGoogle Scholar
  6. 6.
    Aida K, Nishida Y, Tanaka S et al (2011) RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes 60:884–889PubMedCrossRefGoogle Scholar
  7. 7.
    Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S (2004) Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329:381–394PubMedCrossRefGoogle Scholar
  8. 8.
    Kobayashi T, Nishida Y, Tanaka S, Aida K (2011) Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 27:965–970PubMedCrossRefGoogle Scholar
  9. 9.
    Bopegamage S, Kovacova J, Vargova A et al (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271–3280PubMedCrossRefGoogle Scholar
  10. 10.
    Oikarinen M, Tauriainen S, Honkanen T et al (2008) Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 51:1796–1802PubMedCrossRefGoogle Scholar
  11. 11.
    Dotta F, Censini S, van Halteren AG et al (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104:5115–5120PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56:185–193PubMedCrossRefGoogle Scholar
  13. 13.
    Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52:1143–1151PubMedCrossRefGoogle Scholar
  14. 14.
    Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2011) Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 54:2417–2420PubMedCrossRefGoogle Scholar
  15. 15.
    Roivainen M, Klingel K (2009) Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52:995–996PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Sara F. Hansson
    • 1
  • Stella Korsgren
    • 2
  • Fredrik Pontén
    • 2
  • Olle Korsgren
    • 2
  1. 1.Proteomics Core FacilityUniversity of GothenburgGothenburgSweden
  2. 2.Department of Immunology, Genetics and PathologyUppsala UniversityUppsalaSweden

Personalised recommendations